| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Wu,Yi-Rui | Chairman | 1.39% | |
| Wu,Ying-Jun | Director | 0.00% | |
| DA ER FU INVESTMENT HOLDINGS CO., LTD. | Director | 17.07% | |
| Xu,Yuan-Zhen | Independent Director | 0.00% | |
| Li,Qing-Yi | Independent Director | 0.00% | |
| Jiang,Chao-Sheng | Independent Director | 0.00% | |
| Lin,Huang-You | Independent Director | 0.00% |
Change Company Name to DR.WU SKINCARE CO., LTD.
2024/07/03
Change Person in Charge to Wu,Yi-Rui
2024/07/03
Change Company Name to DALFU BIOTECHNOLOGY CO., LTD. (FORMER NAME: TIANYU BIOTECHNOLOGY CO., LTD.)
2021/08/03
Change Person in Charge to Da Er,Fu-Tou-Zi-Kong-Gu-Gu-Fen-You-Xian-Gong-Si
2021/08/03
Change Company Name to DR.WU SKINCARE CO., LTD.
2014/05/06
Change Capital to 500,000,000
2013/08/07
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 347,020 | 1,241,755 | 1,137,145 |
| Operating cost | 94,971 | 363,675 | 323,122 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 252,049 | 878,080 | 814,023 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 252,049 | 878,080 | 814,023 |
| Operating expenses | 79,739 | 353,080 | 324,047 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 172,310 | 525,000 | 489,976 |
| Non-operating income and expenses | 20,396 | 70,323 | 35,791 |
| Net profit (loss) before tax | 192,706 | 595,323 | 525,767 |
| Income tax expense (benefits) | 37,868 | 119,070 | 101,034 |
| Net profit (loss) of ongoing business for the current period | 154,838 | 476,253 | 424,733 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 154,838 | 476,253 | 424,733 |
| Other comprehensive profit (loss), net | - | 0 | -28,948 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 154,838 | 476,253 | 395,785 |
| Net profit (loss) attributable to owners of parent company | 154,838 | 476,253 | 424,733 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 154,838 | 476,253 | 395,785 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 3 | 10 | 9 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 139,503 | 437,181 | 392,440 |
| Net cash inflows (outflows) from investing activities | -230,620 | -89,206 | -108,643 |
| Net cash inflow (outflow) from financing activities | -2,423 | -505,360 | -460,466 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | -93,540 | -157,385 | -176,669 |
| Beginning balance of cash and cash equivalents | 317,496 | 474,881 | 651,550 |
| Ending balance of cash and cash equivalents | 223,956 | 317,496 | 474,881 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,395,135 | 1,268,742 | 1,624,697 |
| Non-current asset | 536,179 | 481,026 | 140,744 |
| Total asset | 1,931,314 | 1,749,768 | 1,765,441 |
| Current liability | 371,161 | 253,199 | 288,875 |
| Non-current liability | 40,356 | 41,515 | 2,241 |
| Total liability | 411,517 | 294,714 | 291,116 |
| share capital | 450,477 | 450,477 | 450,477 |
| Equity - secruity token | - | - | - |
| capital reserve | 241,795 | 241,795 | 331,890 |
| retained earning | 827,525 | 762,782 | 691,958 |
| Other equity | - | 0 | 0 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,519,797 | 1,455,054 | 1,474,325 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,519,797 | 1,455,054 | 1,474,325 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 33 | 32 | 32 |
